Histology equipment market seen reaching $0.83 billion by 2030

The global histology equipment market is projected to rise from $0.68 billion in 2025 to $0.83 billion by 2030, driven by cancer diagnostics, precision medicine and digital pathology investments. North America led the market in 2025, while Asia-Pacific is expected to post the fastest growth.

Why it matters: - Histology equipment sits at the center of tissue-based diagnosis, cancer staging and life sciences research. - Growing demand could push labs, hospitals and research centers to invest more in automation, digital pathology and slide scanning. - The market’s forecast growth signals sustained need for faster and more accurate tissue analysis in clinical and research settings.

What happened: - The Business Research Company published its Histology Equipment Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035. - The market is estimated at $0.68 billion in 2025 and is forecast to reach $0.71 billion in 2026. - The report projects the market will reach $0.83 billion by 2030. - The forecast implies a 4.4% CAGR from 2025 to 2026 and a 3.9% CAGR through 2030. - The report says North America held the largest share of the market in 2025. - The report says Asia-Pacific is expected to be the fastest-growing region during the forecast period. - The market coverage includes Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

The details: - Histology equipment includes instruments used to prepare, process, stain and analyze biological tissue samples. - The equipment supports microscopic tissue examination for disease diagnosis, research and education. - Recent market growth has been linked to broader use of histopathology, expansion of hospital and diagnostic lab capacity, higher cancer incidence, academic research activity and laboratory automation. - Future growth is expected to be driven by precision medicine diagnostics, digital pathology investments, pharmaceutical and biotechnology pipelines, and more clinical trial activity. - The report highlights automated histology workflows, digital pathology, slide scanning technologies and workflow standardization as major trends. - Cancer remains a key demand driver because histology helps identify cancer type and stage and supports treatment decisions. - In July 2024, the Australian Institute of Health and Welfare reported cancer diagnoses in Australia rose from 160,570 in 2022 to 164,694 in 2023. - The report’s 2026 package includes market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample of the report is available through the sample report. - The full report is available through the market report.

Between the lines: - The market outlook points to a shift from manual tissue analysis toward more standardized and automated lab workflows. - Digital pathology appears to be moving from a niche capability to a central buying priority for labs and research institutions. - Rising cancer incidence gives the market a durable clinical demand base rather than a purely technology-driven growth story.

What's next: - Labs and diagnostic providers are likely to keep investing in automation and digital pathology platforms to improve speed and consistency. - Pharmaceutical and biotech research spending could add further demand as clinical trials and precision medicine programs expand. - Regional growth may increasingly tilt toward Asia-Pacific as healthcare infrastructure and research activity scale up.